Marie Krousel-Wood1, Elizabeth Holt, Cara Joyce, Rachael Ruiz, Adriana Dornelles, Larry S Webber, Donald E Morisky, Edward D Frohlich, Richard N Re, Jiang He, Paul K Whelton, Paul Muntner. 1. aDepartment of Medicine, Tulane University School of Medicine bCenter for Health Research, Ochsner Clinic Foundation cDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine dDepartment of Biostatistics and Bioinformatics, Tulane University School of Public Health and Tropical Medicine eOffice of Medical Education, Tulane University School of Medicine, New Orleans, Louisiana (work done while at the Center for Health Research, Ochsner Clinic Foundation) fDepartment of Community Health Sciences, UCLA Fielding School of Public Health, Los Angeles, California gDepartment of Cardiology-Hypertension Section, Ochsner Clinic Foundation, New Orleans, Louisiana hDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Abstract
BACKGROUND: Pharmacy refill adherence assesses the medication-filling behaviors, whereas self-report adherence assesses the medication-taking behaviors. We contrasted the association of pharmacy refill and self-reported antihypertensive medication adherence with blood pressure (BP) control and cardiovascular disease (CVD) incidence. METHODS AND RESULTS: Adults (n = 2075) from the prospective Cohort Study of Medication Adherence among Older Adults recruited between August 2006 and September 2007 were included. Antihypertensive medication adherence was determined using a pharmacy refill measure, medication possession ratio (MPR; low, medium, and high MPR: <0.5, 0.5 to <0.8, and ≥0.8, respectively) and a self-reported measure, eight-item Morisky Medication Adherence Scale (MMAS-8; low, medium, and high MMAS-8: <6, 6 to <8, and 8, respectively). Incident CVD events (stroke, myocardial infarction, congestive heart failure, or CVD death) through February 2011 were identified and adjudicated. The prevalence of low, medium, and high adherence was 4.5, 23.7, and 71.8% for MPR and 14.0, 34.3, and 51.8% for MMAS-8, respectively. During a median of 3.8 years' follow-up, 240 (11.5%) people had a CVD event. Low MPR and low MMAS-8 were associated with uncontrolled BP at baseline and during follow up. After multivariable adjustment and compared to those with high MPR, the hazard ratios for CVD associated with medium and low MPR were 1.17 [95% confidence interval (CI) 0.87-1.56)] and 1.87 (95% CI: 1.06-3.30), respectively. Compared to those with high MMAS-8, the hazard ratios (95% CI) for MMAS-8 for medium and low MMAS-8 were 1.04 (0.79-1.38) and 0.89 (0.58-1.35), respectively. CONCLUSION: While both adherence measures were associated with BP control, pharmacy refill but not self-report antihypertensive medication adherence was associated with incident CVD. The differences in these associations may be because of the distinctions in what each adherence measure assesses.
BACKGROUND: Pharmacy refill adherence assesses the medication-filling behaviors, whereas self-report adherence assesses the medication-taking behaviors. We contrasted the association of pharmacy refill and self-reported antihypertensive medication adherence with blood pressure (BP) control and cardiovascular disease (CVD) incidence. METHODS AND RESULTS: Adults (n = 2075) from the prospective Cohort Study of Medication Adherence among Older Adults recruited between August 2006 and September 2007 were included. Antihypertensive medication adherence was determined using a pharmacy refill measure, medication possession ratio (MPR; low, medium, and high MPR: <0.5, 0.5 to <0.8, and ≥0.8, respectively) and a self-reported measure, eight-item Morisky Medication Adherence Scale (MMAS-8; low, medium, and high MMAS-8: <6, 6 to <8, and 8, respectively). Incident CVD events (stroke, myocardial infarction, congestive heart failure, or CVD death) through February 2011 were identified and adjudicated. The prevalence of low, medium, and high adherence was 4.5, 23.7, and 71.8% for MPR and 14.0, 34.3, and 51.8% for MMAS-8, respectively. During a median of 3.8 years' follow-up, 240 (11.5%) people had a CVD event. Low MPR and low MMAS-8 were associated with uncontrolled BP at baseline and during follow up. After multivariable adjustment and compared to those with high MPR, the hazard ratios for CVD associated with medium and low MPR were 1.17 [95% confidence interval (CI) 0.87-1.56)] and 1.87 (95% CI: 1.06-3.30), respectively. Compared to those with high MMAS-8, the hazard ratios (95% CI) for MMAS-8 for medium and low MMAS-8 were 1.04 (0.79-1.38) and 0.89 (0.58-1.35), respectively. CONCLUSION: While both adherence measures were associated with BP control, pharmacy refill but not self-report antihypertensive medication adherence was associated with incident CVD. The differences in these associations may be because of the distinctions in what each adherence measure assesses.
Authors: Alfredo Dias Oliveira-Filho; José Augusto Barreto-Filho; Sabrina Joany Felizardo Neves; Divaldo Pereira de Lyra Junior Journal: Arq Bras Cardiol Date: 2012-06-07 Impact factor: 2.000
Authors: Marie Krousel-Wood; Cara Joyce; Elizabeth Holt; Paul Muntner; Larry S Webber; Donald E Morisky; Edward D Frohlich; Richard N Re Journal: Hypertension Date: 2011-10-03 Impact factor: 10.190
Authors: Israel M Barbash; Michael A Gaglia; Rebecca Torguson; Sa'ar Minha; Lowell F Satler; Augusto D Pichard; Ron Waksman Journal: Am Heart J Date: 2013-08-29 Impact factor: 4.749
Authors: Marie Krousel-Wood; Tareq Islam; Larry S Webber; Richard N Re; Donald E Morisky; Paul Muntner Journal: Am J Manag Care Date: 2009-01 Impact factor: 2.229
Authors: Marie A Krousel-Wood; Paul Muntner; Tareq Islam; Donald E Morisky; Larry S Webber Journal: Med Clin North Am Date: 2009-05 Impact factor: 5.456
Authors: Gabrielle K Y Lee; Harry H X Wang; Kirin Q L Liu; Yu Cheung; Donald E Morisky; Martin C S Wong Journal: PLoS One Date: 2013-04-25 Impact factor: 3.240
Authors: Nanette K Wenger; Caroline Lloyd Doherty; Jerry H Gurwitz; Glenn A Hirsch; Holly M Holmes; Matthew S Maurer; Michael D Murray Journal: Drugs Aging Date: 2017-11 Impact factor: 3.923
Authors: LaKeisha G Williams; Erin Peacock; Cara Joyce; Lydia A Bazzano; Daniel Sarpong; Paul K Whelton; Elizabeth W Holt; Richard Re; Edward Frohlich; Jiang He; Paul Muntner; Marie Krousel-Wood Journal: Am J Med Sci Date: 2018-07-29 Impact factor: 2.378